tripchlorolide has been researched along with Alzheimer Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Dai, X; Lin, N; Lu, J; Pan, X; Shen, H; Zeng, Y; Zhang, J; Zhou, M; Zhu, Y | 1 |
1 other study(ies) available for tripchlorolide and Alzheimer Disease
| Article | Year |
|---|---|
Tripchlorolide improves cognitive deficits by reducing amyloid β and upregulating synapse-related proteins in a transgenic model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cognition; Diterpenes; Humans; Immunosuppressive Agents; Maze Learning; Mice; Mice, Transgenic; Phenanthrenes; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psychomotor Performance; Synapses; TOR Serine-Threonine Kinases | 2015 |